Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Mol Cell Endocrinol ; 589: 112250, 2024 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-38663485

RESUMO

The most common form of hypercortisolism is iatrogenic Cushing's syndrome. Lipodystrophy and metabolic disorders can result from the use of exogenous glucocorticoids (GC). Adipocytes play an important role in the production of circulating exosomal microRNAs, and knockdown of Dicer promotes lipodystrophy. The aim of this study is to investigate the effect of GCs on epididymal fat and to assess their influence on circulating microRNAs associated with fat turnover. The data indicate that despite the reduction in adipocyte volume due to increased lipolysis and apoptosis, there is no difference in tissue mass, suggesting that epididymal fat pad, related to animal size, is not affected by GC treatment. Although high concentrations of GC have no direct effect on epididymal microRNA-150-5p expression, GC can induce epididymal adipocyte uptake of microRNA-150-5p, which regulates transcription factor Ppar gamma during adipocyte maturation. In addition, GC treatment increased lipolysis and decreased glucose-derived lipid and glycerol incorporation. In conclusion, the similar control and GC epididymal fat mass results from increased dense fibrogenic tissue and decreased adipocyte volume induced by the lipolytic effect of GC. These findings demonstrate the complexity of epididymal fat. They also highlight how this disease alters fat distribution. This study is the first in a series published by our laboratory showing the detailed mechanism of adipocyte turnover in this disease.


Assuntos
Adipócitos , Epididimo , Glucocorticoides , Lipólise , MicroRNAs , Masculino , Animais , MicroRNAs/metabolismo , MicroRNAs/genética , Epididimo/efeitos dos fármacos , Epididimo/metabolismo , Epididimo/patologia , Adipócitos/efeitos dos fármacos , Adipócitos/metabolismo , Glucocorticoides/efeitos adversos , Glucocorticoides/farmacologia , Lipólise/efeitos dos fármacos , Camundongos , Apoptose/efeitos dos fármacos , Camundongos Endogâmicos C57BL , PPAR gama/metabolismo , PPAR gama/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA